First-line treatment of seasonal (ragweed) rhinoconjunctivitis

 

Table 2: Differences in mean scores for health-related quality of life (HRQL)* between the treatment groups (after adjustment for differences at baseline)
DomainDifference in mean scores† p value§
Height of season‡ End of season‡Treatment effect Time effect
Sleep impairment

Non-nasal symptoms

Practical problems

Nasal symptoms

Eye symptoms

Activity limitations

Emotional function

-0.03

0.17

0.15

0.21

-0.27

0.20

0.23

0.15

0.09

0.39

0.31

0.04

0.33

0.05

0.054

0.274

0.015

0.005

0.614

0.037

0.165

0.0037

0.0052

0.0001

0.0035

0.0001

0.0002

0.0003

Overall0.110.14 0.0520.0001
*HRQL determined using Rhinoconjunctivitis Quality of Life Questionnaire3 scores (0 = not bothered, 6 = extremely bothered).
†Minimal important difference = 0.5.
‡Positive differences indicate better HRQL for patients in the fluticasone group.
§Repeated measures analysis with covariate adjustment for differences in baseline score.

[Return to text]


| CMAJ April 15, 1997 (vol 156, no 8) / JAMC le 15 avril 1997 (vol 156, no 8) |
/ >